For coagulation tests and as a rinsing solution for the sample needles of the Sy
For coagulation tests and as a rinsing solution for the sample needles of the Sysmex® CA Systems
N/T Protein Control SL/M is a medium level, multi-analyte control for use as acc
N/T Protein Control SL/M is a medium level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems
N/T Protein Control SL/H is a high level, multi-analyte control for use as accur
N/T Protein Control SL/H is a high level, multi-analyte control for use as accuracy and precision control in the determination of human serum proteins by immunonephelometry with the BN Systems
For the determination of the activity of coagulation factor X in human plasma by
For the determination of the activity of coagulation factor X in human plasma by coagulometric methods
For the determination of the activity of coagulation factor XI in human plasma b
For the determination of the activity of coagulation factor XI in human plasma by coagulometric methods
Quantitative determination of soluble transferrin receptor (sTfR) in human serum
Quantitative determination of soluble transferrin receptor (sTfR) in human serum and heparinized plasma on BN Systems
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lu
LA 1 Screening Reagent. Simplified DRVV reagent to screen for the presence of Lupus Anticoagulants
For use as a low level assayed control for the quantitative measurement of low m
For use as a low level assayed control for the quantitative measurement of low molecular weight heparin with Berichrom Heparin
For calibration of the Berichrom Heparin assay for measurement of low molecular
For calibration of the Berichrom Heparin assay for measurement of low molecular weight heparin
JPA
SYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
For use as a high level assayed control for the quantitative measurement of unfr
For use as a high level assayed control for the quantitative measurement of unfractionated heparin with Berichrom Heparin
Quantitative determination of homocysteine in human serum and plasma on BN II an
Quantitative determination of homocysteine in human serum and plasma on BN II and BN ProSpec® Systems
CYSC CON L is an assayed intralaboratory quality control for assessment of preci
CYSC CON L is an assayed intralaboratory quality control for assessment of precision and analytical bias in the determination of the CYSC method on the Dimension Vista® System
PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality con
PROT1 CON M is an assayed, mid-level, intralaboratory, multi-analyte quality control for the assessment of precision and analytical bias on the Dimension Vista® System
For the quantitative measurement of immunoglobulin E in human serum and plasma (
For the quantitative measurement of immunoglobulin E in human serum and plasma (heparin or EDTA) on the Dimension Vista® System
DGC
IGE, ANTIGEN, ANTISERUM, CONTROL
DImension Vista® Immunoglobulin E Flex® reagent cartridge
For the quantitative measurement of C-reactive protein in human serum and plasma
For the quantitative measurement of C-reactive protein in human serum and plasma on the Dimension Vista® System
NQD
CARDIAC C-REACTIVE PROTEIN, ANTIGEN, ANTISERUM, AND CONTROL
For the quantitative measurement of total homocysteine in human serum and plasma
For the quantitative measurement of total homocysteine in human serum and plasma on the Dimension Vista® System
The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantita
The DIMERTEST® Latex Assay is intended for the rapid qualitative or semiquantitative evaluation of circulating derivatives of cross-linked fibrin degradation products (XL-FDP) in human plasma
DAP
FIBRINOGEN AND FIBRIN SPLIT PRODUCTS, ANTIGEN, ANTISERUM, CONTROL
For differential staining in hematology that gives results similar to a Wright-G
For differential staining in hematology that gives results similar to a Wright-Giemsa stain
Assayed accuracy and precision controls in the determination of free light chain
Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems.
Assayed accuracy and precision controls in the determination of free light chain
Assayed accuracy and precision controls in the determination of free light chains (FLC) type kappa and type lambda on BN Systems.
The BN ProSpec® is a system for the quantitative determination of proteins in se
The BN ProSpec® is a system for the quantitative determination of proteins in serum, plasma, urine and CSF
Quantitative determination of carbohydrate-deficient transferrin (CDT) in human
Quantitative determination of carbohydrate-deficient transferrin (CDT) in human serum on BN II and BN ProSpec® Systems
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
Qualitative detection or semi-quantitative determination of C-reactive protein (
Qualitative detection or semi-quantitative determination of C-reactive protein (CRP) in human serum
A pool of normal citrated human plasma collected from a minimum of 20 donors, bu
A pool of normal citrated human plasma collected from a minimum of 20 donors, buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity.
A pool of citrated normal human plasma collected from a minimum of 20 donors, an
A pool of citrated normal human plasma collected from a minimum of 20 donors, and diluted to defined concentrations. Plasma is buffered with 0.05M HEPES and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays in the normal range, including fibrinogen, coagulation factors II, V, VII, VIII, IX, X XI and XII, ATIII activity, Protein C activity and Protein S activity.
A pool of citrated human plasma collected from a minimum of 20 donors that has b
A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the highly abnormal range.
A pool of citrated human plasma collected from a minimum of 20 donors that has b
A pool of citrated human plasma collected from a minimum of 20 donors that has been depleted of specific clotting factors. The plasma is buffered with 0.05M HEPES buffer and stabilizers, dispensed, and lyophilized. This plasma is used for the quality control of coagulation assays (PT and APTT) in the mid-level abnormal range.
A pool of normal citrated human plasma collected from a minimum of 20 donors, bu
A pool of normal citrated human plasma collected from a minimum of 20 donors, buffered with 0.05M HEPES buffer and stabilizers, dispensed and lyophilized. This plasma is used for the quality control of coagulation assays (PT, APTT and Fibinogen) in the normal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT), in the mid-level abnormal range.
Intended for use in the quality control of quantitative coagulation assays, incl
Intended for use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.
Intended for the use in the quality control of quantitative coagulation assays,
Intended for the use in the quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.
Intended for the use in quality control of quantitative coagulation assays, incl
Intended for the use in quality control of quantitative coagulation assays, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and Fibrinogen, in the normal range.
Intended for use in the quality control of coagulation assays in the borderline
Intended for use in the quality control of coagulation assays in the borderline pathological range.
Intended for use in the quality control of coagulation assays in the borderline
Intended for use in the quality control of coagulation assays in the borderline pathological range.
Assayed control plasma prepared from de-fibrinated human plasma intended for use
Assayed control plasma prepared from de-fibrinated human plasma intended for use in the quality control of quantitative fibrinogen assays in the low abnormal range.
Assayed control plasma prepared from de-fibrinated human plasma intended for use
Assayed control plasma prepared from de-fibrinated human plasma intended for use in the quality control of quantitative fibrinogen assays in the low abnormal range.
Assayed control plasma prepared from de-fibrinated human plasma intended for use
Assayed control plasma prepared from de-fibrinated human plasma intended for use in the quality control of quantitative fibrinogen assays in the low abnormal range.